Skip to main content
. 2015 Oct 20;6(41):43653–43666. doi: 10.18632/oncotarget.6189

Table 3. Gene set enrichment analysis for differentially expressed genes in low grade and high grade phenotype of case 2.

Gene Set Name # Genes in Gene Set (K) # Genes in Overlap (k) k/K Enrichment score (ES) p-value FDR q-value
A. Gene sets enriched with genes over-expressed in high grade phenotype
(a) MILI_PSEUDOPODIA_HAPTOTAXIS_DN 668 41 0.0614 0.2736 8.04E-22 3.80E-18
(b) GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN 1080 50 0.0463 0.1704 4.58E-21 1.08E-17
(c) PATIL_LIVER_CANCER 747 31 0.0415 0.2521 3.19E-12 1.07E-9
(d) MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 1069 47 0.0440 0.2492 5.88E-19 9.25-16
(e) VERHAAK_GLIOBLASTOMA_PRONEURAL 210 21 0.1000 0.3899 6.36E-16 6.00E-13
(f) REACTOME_BETA_DEFENSINS 42 11 0.2619 0.8475 9.75E-14 5.76E-11
(g) BENPORATH_SUZ12_TARGETS 1038 43 0.0414 0.2278 1.70e-16 2.01E-13
B. Gene sets enriched with genes underexpressed in high grade phenotype
(a) BLALOCK_ALZHEIMERS_DISEASE_UP 1691 48 0.0284 −0.2388 3.69E-12 1.16E-9
(b) LU_AGING_BRAIN_UP 262 17 0.0649 −0.3781 3.77E-10 8.09E-8